Ebersberg, Germany and Mount Prospect, Illinois, USA
05. October, 2011
Eurofins MWG Operon and Integrated Genomics have announced a co-operation agreement to combine their expertise in sequencing and analysis services for microbial, fungal, and algal organisms. Integrated Genomics, based in Mount Prospect, Illinois, is the leading commercial provider of microbial bioinformatics tools and services based on the ERGO™ genome sequence analysis platform. Eurofins MWG Operon, based in Ebersberg, Germany, and a member of the Eurofins Group, is one of the leading global providers of DNA sequencing services, DNA synthesis products and bioinformatics services for academic and industrial research.
The goal of the cooperation is to provide customers “one-stop-shopping” for complete genomics projects that delivers analysis results from the raw extracted DNA. Both companies together serve a worldwide market for their products and services.
“We take specific care to build up a technical and operational pipeline which is suitable to meet our quality standards and the high service level we want to provide to our customers”, says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. “The specific know-how and bioinformatics capabilities of Integrated Genomics are an excellent fit to our portfolio for prokaryotic, yeast and fungal genome sequencing services.”
“As a leader in the next generation sequencing technology, Eurofins has long been our preferred sequencing partner. With this increased integration we are now able to provide complete genome sequencing and analysis projects for our customers”, says John W. Elling, CEO of Integrated Genomics.
Eurofins MWG Operon, a member of the Eurofins Group with major offices and production facilities in Europe, the United States, and Asia, is an international provider of DNA sequencing services, DNA synthesis products and bioinformatic services for academic and industrial research. As the pioneering service provider for next generation sequencing, Eurofins MWG Operon has established profound know-how and proprietary protocols to cover a broad range of applications including de novo sequencing, professional project consulting and innovative developments in library generation for a wide range of genomes of any size. The company’s strength is its strong customer orientation, fast service, and high quality.
For further information, please visit our website at: www.eurofinsdna.com
Integrated Genomics, (IG Assets Inc., Chicago IL) is the leading commercial provider of microbial bioinformatics tools and services based on the ERGO™ genome sequence analysis platform, including ORF-calling, annotation, databases for genome comparison, metabolic analysis and metabolic reconstruction. The company’s expertise in microbial genomics includes genome assembly annotations, comparative genomics and custom bioinformatics applications. ERGO™ contains the largest available integration of microbial genome data, including genome-derived metabolic reconstructions representing over 6,800 networked metabolic and non-metabolic pathways.
For further information, please visit our website at: http://www.integratedgenomics.com
Topics
Species
